Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia J Müller

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|February 15, 2008
Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activationRadoslaw M Sobota, Pia J Müller, Peter C Heinrich, et al.
European Journal of Cell Biology|December 6, 2011
Interleukin-6 signalling: more than Jaks and STATsRené Eulenfeld, Anna Dittrich, Christina Khouri, et al.
Cellular Signalling|May 3, 2008
SHPS-1/SIRP1alpha contributes to interleukin-6 signallingRadoslaw M Sobota, Pia J Müller, Christina Khouri, et al.
Journal of Proteomics|April 16, 2013
Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemiaPia J Müller, Kristoffer T G Rigbolt, Dirk Paterok, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|February 15, 2008
Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activationRadoslaw M Sobota, Pia J Müller, Peter C Heinrich, et al.
European Journal of Cell Biology|December 6, 2011
Interleukin-6 signalling: more than Jaks and STATsRené Eulenfeld, Anna Dittrich, Christina Khouri, et al.
Cellular Signalling|May 3, 2008
SHPS-1/SIRP1alpha contributes to interleukin-6 signallingRadoslaw M Sobota, Pia J Müller, Christina Khouri, et al.
Journal of Proteomics|April 16, 2013
Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemiaPia J Müller, Kristoffer T G Rigbolt, Dirk Paterok, et al.
Pageof 1